PMID: 6403136Mar 19, 1983Paper

Rifampicin reduces effectiveness and bioavailability of prednisolone

British Medical Journal
W A McAllisterH J Rogers

Abstract

Rifampicin is an inducer of hepatic drug metabolising enzymes. This results in interactions with several drugs including oral anticoagulants, hypoglycaemics, and contraceptives. Concurrent treatment with prednisolone and rifampicin is given when tuberculosis coexists with a disease that is sensitive to steroids, when the diagnosis is uncertain, or occasionally in the treatment of severe tuberculosis. Two patients with respiratory disease were treated with both drugs: their condition improved considerably after rifampicin was withdrawn. Seven patients were then studied to assess the effect of rifampicin on the pharmacokinetics of prednisolone. Overall, rifampicin increased the plasma clearance of prednisolone by 45% and reduced the amount of drug available to the tissues (area under the plasma concentration time curve) by 66%. The effectiveness of prednisolone may be considerably reduced when rifampicin and prednisolone are used in combination.

References

May 1, 1979·Clinical Pharmacology and Therapeutics·A TannerL Powell
Oct 25, 1976·JAMA : the Journal of the American Medical Association·G A BuffingtonJ Lemann
Oct 1, 1977·British Journal of Clinical Pharmacology·P J MorrisonH J Rogers
Sep 7, 1974·Lancet·O M EdwardsA D Tait
Mar 1, 1972·European Journal of Clinical Pharmacology·B SchoeneH F von Oldershausen
Jan 1, 1974·Drug Metabolism Reviews·M Gibaldi, D Perrier
Oct 1, 1973·Biochemical Medicine·H GreimH Popper
Sep 1, 1974·Annals of Internal Medicine·R A O'Reilly
Feb 1, 1980·Journal of Pharmacokinetics and Biopharmaceutics·J G GambertoglioL Z Benet
Jan 1, 1981·European Journal of Clinical Pharmacology·E L ToverudD S Davies
Nov 1, 1980·British Journal of Clinical Pharmacology·S Al-Habet, H J Rogers

❮ Previous
Next ❯

Citations

Jan 1, 1984·European Journal of Clinical Pharmacology·E LanghoffE F Hvidberg
Jul 4, 2012·Current HIV/AIDS Reports·Graeme MeintjesSuzaan Marais
Nov 1, 1990·Transactions of the Royal Society of Tropical Medicine and Hygiene·F MugusiD G McLarty
Oct 29, 1983·Lancet·P O Brennan
Apr 27, 1985·Lancet·R D AllenP J Morris
Dec 27, 1984·The New England Journal of Medicine·D EngelhardM I Marks
Oct 24, 1998·Genes & Development·B BlumbergR M Evans
Sep 29, 2011·HIV Medicine·A L PozniakUNKNOWN BHIVA Guidelines Subcommittee
Jan 1, 2011·BMJ Case Reports·Sakthiswary RajalinghamFauzi Md Anshar
Apr 28, 1984·British Medical Journal·N W Horne
Jul 7, 1984·British Medical Journal·A J Davies, D A Lewis
May 1, 1989·Thorax·D J BarnesJ R Turtle
Feb 18, 2003·American Journal of Respiratory and Critical Care Medicine·Henry M BlumbergUNKNOWN American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society
Feb 17, 2006·Annals of Clinical Microbiology and Antimicrobials·Jiezhong Chen, Kenneth Raymond
Oct 3, 2012·PLoS Neglected Tropical Diseases·N Deborah FriedmanDaniel P O'Brien
Jul 29, 2003·Clinical Pharmacokinetics·Mikko NiemiKari T Kivistö
Dec 2, 2010·The American Journal of Tropical Medicine and Hygiene·Tom HellerEnrico Brunetti
Jul 1, 1990·Journal of Endocrinological Investigation·F BeniniL Vettore
Jun 19, 2007·Médecine et maladies infectieuses·P Tattevin
Sep 25, 2010·Revue des maladies respiratoires·L FekihM L Megdiche
Jan 1, 2012·Retinal Cases & Brief Reports·Zac B RavagePauline T Merrill
Jan 1, 1993·Scandinavian Journal of Infectious Diseases·N Heurlin, B Petrini
Mar 13, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·W W Yew
May 11, 2012·Enfermedades infecciosas y microbiología clínica·Soledad BerdaguerJosé Miguel Cisneros
Feb 1, 1996·Chest·P Clarke, M B Allen
Nov 8, 2011·Infectious Disease Clinics of North America·Robert S Wallis
Nov 15, 2011·European Journal of Internal Medicine·Nicolas JavaudOlivier Fain
Aug 3, 2010·Infectious Disease Clinics of North America·Robert S Wallis, Neil W Schluger
Jul 19, 2015·The British Journal of Ophthalmology·Rupesh AgrawalCarlos E Pavesio
Jan 1, 1986·British Journal of Diseases of the Chest·M E Ellis, F Tayoub
Mar 1, 1989·Tubercle·E G WilkinsA Cope
Apr 9, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Y MeijeUNKNOWN ESCMID Study Group of Infection in Compromised Hosts
Jul 17, 2015·Journal of Ophthalmic Inflammation and Infection·Rosalynn Grace SiantarRupesh Agrawal
Aug 29, 2014·International Journal of Endocrinology·Jagriti UpadhyayNitin Trivedi
Feb 11, 2015·Mayo Clinic Proceedings·Badr F Al BawardyMatthew T Drake

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Postgraduate Medical Journal
S Ward, C C Evans
The Journal of Allergy and Clinical Immunology
F L Lin
British Journal of Clinical Pharmacology
R J HermanA J Wood
European Journal of Clinical Pharmacology
D KandiahM J Lewis
© 2021 Meta ULC. All rights reserved